S 3105 · 115th Congress · Health

Pharmaceutical Origin Transparency Act of 2018

Introduced 2018-06-21· Sponsored by Sen. McCaskill, Claire [D-MO]· Senate

Bill Progress

✓
Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2018-06-21)

Plain Language Summary

[AI summary unavailable — showing source text] Pharmaceutical Origin Transparency Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)…

Summarized by Claude AI · Non-partisan · For informational purposes only